Expert analysis on FDA approvals, clinical trials, PDUFA dates, and biotech investing strategies
The complete Q2 2026 FDA calendar with every PDUFA decision, Phase 3 data readout, and NDA filing between April and June 2026. Includes Probability of Approval scores, deep dives on BIIB, ARGX, AZN, A...
The biggest moves in biotech happen around catalysts like PDUFA dates and data readouts. This guide reveals how top hedge funds like Baker Brothers and OrbiMed position before FDA decisions, what insi...
Most biotech investors skip due diligence and pay the price. This step-by-step checklist walks you through everything you need to evaluate before buying a biotech stock: the drug pipeline, clinical da...
Clinical trial data is the single most important factor in biotech investing, but most investors struggle to read it. This guide breaks down Phase 1, 2, and 3 trials, explains what endpoints like over...